News Archive

Professor Sir Aziz Sheikh: Towards next-generation pharmacovigilance capabilities for the UK

12th January 2026

The MHRA’s latest strategy blog — written by Professor Sir Aziz Sheikh — sets out ideas for transforming how the UK monitors medicine and medical product safety using real-world data and digital systems.

Read More+

MHRA welcomes Professor Jacob George as he starts Chief Medical and Scientific Officer role

6th January 2026

Professor Jacob George has started as MHRA’s first ever Chief Medical and Scientific Officer, bringing senior clinical and scientific leadership to the regulator.

Read More+

2025 in MedTech: a year of innovation, global leadership and regulatory milestones

24th December 2025

The MHRA reflects on key med-tech achievements and regulatory milestones from 2025.

Read More+

2025 – A year of collaboration, new beginnings and long-standing commitments (EDQM)

24th December 2025

EDQM reflects on a year of major change — strengthening partnerships, modernising the European Pharmacopoeia and reaffirming its public-health mission.

Read More+

Concept Paper on the revision of Annex 3 of the guidelines on Good Manufacturing Practice for Radiopharmaceuticals

24th December 2025

EMA has launched a concept paper to modernise GMP Annex 3 for radiopharmaceuticals, reflecting major scientific and regulatory changes since 2008.

Read More+

EMA Management Board: highlights of December 2025 meeting

24th December 2025

EMA’s Management Board welcomed political agreement on new EU pharma legislation and set out priorities and investment plans for 2026 and beyond.

Read More+

FDA guidance on using Real-World Evidence (RWE) for medical device regulatory decisions

24th December 2025

The FDA has updated guidance on how Real-World Evidence can support medical device approvals and post-market decisions.

Read More+

FDA sets out investigator responsibilities for safety reporting in investigational drug and device studies

24th December 2025

The FDA has published draft guidance clarifying what investigators must report, and when, during clinical research involving investigational drugs and devices.

Read More+

MHRA seeks input on AI regulation at ‘pivotal moment’ for healthcare

24th December 2025

The MHRA is asking the public, clinicians and industry to help shape future rules for AI in healthcare. Link to press release.

Read More+

Processes and practices applicable to Bioresearch Monitoring (BIMO) inspections (FDA)

24th December 2025

The FDA has issued final guidance setting out what sponsors and research sites should expect during BIMO inspections, and how to manage inspection communications and records requests.

Read More+